STOCK TITAN

Organogenesis Holdings Inc. to Present at the Oppenheimer Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Organogenesis Holdings Inc. (Nasdaq: ORGO) will participate in Oppenheimer’s 32nd Annual Healthcare Conference on March 15-16, 2022. The management team is scheduled to present on March 15 at 10:40 a.m. Eastern Time. A live audio webcast of the presentation will be available on the company’s website, with a replay accessible for 30 days afterwards. Organogenesis focuses on regenerative medicine, offering advanced wound care and surgical products designed to meet various patient needs.

Positive
  • None.
Negative
  • None.

CANTON, Mass., March 08, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that company management will participate in Oppenheimer’s 32nd Annual Healthcare Conference, which is being held virtually from March 15th-16th. Management will present on Tuesday, March 15th at 10:40 a.m. Eastern Time.

A live audio webcast of the conference presentation will be accessible by visiting the “Upcoming Events” section on the “Investor Relations” page of Organogenesis’s website www.organogenesis.com. An archive of the webcast will be available for replay following the conference for approximately 30 days.

About Organogenesis Holdings Inc.

Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis’s comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs. For more information, visit www.organogenesis.com.


FAQ

When is Organogenesis participating in Oppenheimer’s Healthcare Conference?

Organogenesis will participate in the Oppenheimer 32nd Annual Healthcare Conference on March 15-16, 2022.

What time will Organogenesis present at the conference?

Organogenesis is set to present on March 15 at 10:40 a.m. Eastern Time.

Where can I watch the Organogenesis conference presentation?

The live audio webcast of the presentation can be accessed on the Investor Relations page of Organogenesis’s website.

How long will the webcast of Organogenesis's presentation be available?

The archive of the webcast will be available for replay for approximately 30 days after the conference.

What products does Organogenesis focus on?

Organogenesis specializes in regenerative medicine products for advanced wound care and surgical applications.

Organogenesis Holdings Inc.

NASDAQ:ORGO

ORGO Rankings

ORGO Latest News

ORGO Stock Data

430.21M
74.14M
43.44%
48.28%
7.85%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
CANTON